For the roles of extracellular S100A8 and S100A9, we used recombinant S100A8 or S100A9 protein (10 μg/ml) to treat CRC cell lines HCT116 and SW480 and found an increase of cell viability and migration. This evidence concerns the gene S100A9 and colorectal carcinoma.